{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:58:35Z","timestamp":1792785515552,"version":"4.5.0"},"reference-count":27,"publisher":"Informa UK Limited","issue":"12-13","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA","id":[{"id":"https:\/\/ror.org\/02891sr49","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/17576180.2026.2728520","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:20:11Z","timestamp":1788754811000},"page":"1065-1074","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Development of a ready-to-use cell-based functional neutralizing antibody assay for MK-1484, a PEGylated IL-2 mutein that preferentially activates effector T-cells"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3862-057X","authenticated-orcid":false,"given":"Dhanvanthri S.","family":"Deevi","sequence":"first","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9165-3705","authenticated-orcid":false,"given":"Aparna","family":"Swarup","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6012-0946","authenticated-orcid":false,"given":"Tatyana","family":"Yun","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-4077","authenticated-orcid":false,"given":"Federico","family":"Ferrari","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8742-1614","authenticated-orcid":false,"given":"Jennifer","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1281-3342","authenticated-orcid":false,"given":"Chuying","family":"Ma","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2116-370X","authenticated-orcid":false,"given":"Nazneen","family":"Bano","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9480-6135","authenticated-orcid":false,"given":"James","family":"Schiller","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0920-4901","authenticated-orcid":false,"given":"Linlin","family":"Luo","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5082-9098","authenticated-orcid":false,"given":"Roy","family":"Helmy","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8181-8335","authenticated-orcid":false,"given":"Faye","family":"Vazvaei-Smith","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7598-1489","authenticated-orcid":false,"given":"Weifeng","family":"Xu","sequence":"additional","affiliation":[{"name":"Merck &","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2015.10.003"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri3156"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-042718-041717"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-011-0517-7"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2014.07.018"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01826-7"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-022-00680-w"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011931"},{"issue":"5","key":"e_1_3_8_11_1","first-page":"1163","article-title":"Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2","volume":"7","author":"Hjelm Skog AL","year":"2001","unstructured":"Hjelm Skog AL, Wadhwa M, Hassan M, et al. Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2. Clin Cancer Res. 2001;7(5):1163\u20131170.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_8_12_1","volume-title":"Immunogenicity testing of therapeutic protein products \u2014developing and validating assays for anti-drug antibody detection","author":"FDA US","year":"2019","unstructured":"FDA US. Immunogenicity testing of therapeutic protein products \u2014developing and validating assays for anti-drug antibody detection. 2019."},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2018.08.003"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2018-0109"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2014.11.005"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/17576180.2025.2608560"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-023-00830-5"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2008.09.020"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-024-00909-7"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-016-9954-6"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2015.02.006"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2012.0027"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1201\/9780203027011"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-9822(06)00369-1"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.23.10772"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.17.10719"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.2056"},{"issue":"2","key":"e_1_3_8_28_1","first-page":"191","article-title":"Monoclonal antibody which has the neutralizing activities for human IL-2","volume":"5","author":"Sato H","year":"1986","unstructured":"Sato H, Natsuume-Sakai S, Miyawaki T, et al. Monoclonal antibody which has the neutralizing activities for human IL-2. J Biol Response Mod. 1986;5(2):191\u2013201.","journal-title":"J Biol Response Mod"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpc.2024.107290"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2728520","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17576180.2026.2728520","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2026.2728520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:19:13Z","timestamp":1791206353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2026.2728520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":27,"journal-issue":{"issue":"12-13","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/17576180.2026.2728520"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2026.2728520","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-04-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}